OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.890
-0.020 (-0.41%)
Nov 16, 2026, 4:00 PM EST - Market closed
OmniAb Revenue
OmniAb had revenue of $3.99M in the quarter ending September 30, 2026, with 78.34% growth. This brings the company's total for the last twelve months to $40.21M, up 90.63% year-over-year. In the year 2025, OmniAb had annual revenue of $18.67M, down -29.27%. That makes OmniAb the 29,525th largest company in the world by revenue and 3,927th in the United States.
Revenue (ttm)
$40.21M
Revenue Growth
+90.63%
P/S Ratio
17.74
Revenue / Employee
$451,809
Employees
89
Market Cap
713.26M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.67M | -7.73M | -29.27% |
| Dec 31, 2024 | 26.39M | -7.77M | -22.75% |
| Dec 31, 2023 | 34.16M | -24.91M | -42.17% |
| Dec 31, 2022 | 59.08M | 24.33M | 70.02% |
| Dec 31, 2021 | 34.75M | 11.48M | 49.34% |
| Dec 31, 2020 | 23.27M | 4.95M | 27.02% |
| Dec 31, 2019 | 18.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apnimed | 108.80M |
| Janux Therapeutics | 23.29M |
| Alumis | 7.24M |
| Prime Medicine | 7.06M |
| Inventiva | 2.81M |
| Attovia Therapeutics | 1.44M |
OABI News
- 7 days ago - OmniAb Slides: Corporate presentation - Filings
- 17 days ago - OmniAb Earnings Call Transcript: Q3 2026 - Transcripts
- 17 days ago - OmniAb Slides: Q3 2026 - Filings
- 17 days ago - OmniAb Earnings release: Q3 2026 - Filings
- 17 days ago - OmniAb Quarterly report: Q3 2026 - Filings
- 17 days ago - OmniAb reports Q3 EPS (12c), consensus (13c) - TheFly
- 17 days ago - OmniAb raises FY26 revenue view $35M-$39M from $32M-$36M, consensus $35.04M - TheFly
- 17 days ago - OmniAb Reports Third Quarter 2026 Financial Results and Business Highlights - Business Wire